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Trials was launched with the ambition of providing
authors with the opportunity to provide all the necessary
detail for a true and complete scientific record [1]. It has
long pushed for the communication of all outcome
measures in health-related randomized controlled trials,
as well as varying analyses and interpretations, and in-
depth descriptions of what was done and what was learnt.
An integral part of this was, of course, the publication
of study protocols, which had rarely been possible in
paper-based journals [2]. A published protocol estab-
lishes precedence, allows more detailed discussion of
methodological issues and can be referenced when
reporting the main trial results [3].
The increasing publication of study protocols is
undoubtedly one of Trials’ greatest successes [4].
However, despite recent movements towards greater
transparency in reporting research, concerns remain
regarding the widespread discrepancies between trial
publications and what was stated in the original study
protocol [5,6]. Indeed, there is strong evidence that
selective outcome reporting, with manipulation of the
outcomes and analyses reported, is a common problem
in medical research [7]. This serves to highlight the
importance of researchers having access to all of the
relevant information, to reliably evaluate bias or selective
reporting in clinical trials.
However, while Trials regularly publishes the results
of trials, primary trial reports are still predominantly
published elsewhere. Although a results paper may
reference a published study protocol, there is nothing
to connect that report to subsequent publications; and
no link from the protocol itself to the results article. This
situation is further complicated by the ever-growing body
of literature. A single clinical trial can result in multiple
publications: the study protocol and traditional results* Correspondence: daniel.shanahan@biomedcentral.com
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lyses and, eventually, systematic reviews, among others [8].
The advent of trial registration has helped to mitigate,
to some extent, the lack of connectivity by providing a
unique identifier associated with each trial record. How-
ever, while major medical journals typically capture the
clinical trial number on or before publication, many do
not follow Trials’ example by publishing it in the abstract,
as is recommended by CONSORT for Abstracts [9] and
the International Committee of Medical Journal Editors
(ICMJE) [10]. The reader thus has to identify related
content through a literature search, using titles, authors
and the abstract; details that will not necessarily remain
consistent, as the articles may be published in different
journals, with different authors, over many years.Threaded publications
In 1999, Chalmers and Altman envisioned a solution.
In their article in The Lancet, they wrote: ‘Electronic
publication of a protocol could be simply the first elem-
ent in a sequence of “threaded” electronic publications,
which continues with reports of the resulting research
(published in sufficient detail to meet some of the
criticisms of less detailed reports published in print
journals), followed by deposition of the complete data
set’ [2]. This was the first description of the threaded
publications initiative.
Building on the concept of trial registration, the aim
of the threaded publications initiative is to link all
publications relating to a single clinical trial centrally,
regardless of journal or publisher, using the clinical trial
number. This means that no matter which article in the
‘thread’ researchers start from, they will be easily able
to identify and gain access to all other publications
relating to that clinical trial. In 2011, we began to put
this linkage into practice within Trials [11]; however, to
achieve its fundamental aims, the project must go
beyond a single journal or publisher.
It was in pursuit of this ambition that, in partnership
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digital-object identifier (DOI) and the more recent Cross-
Mark tool, which provides information on the status of the
associated article and an additional publication record, to
achieve the threaded publications concept [12]. The
meeting spurred the formation of a working group to
govern the development of the project. Chaired by BioMed
Central, the working group includes representatives from
CrossRef, BMJ, Canadian Medical Associate Journal, the
Cochrane Collaboration, eLife, F1000, the Internal Stand-
ard Randomized Controlled Trial Number (ISRCTN)
Registry, The Lancet, Origin Editorial, the Public Library of
Science, Springer, The Wellcome Trust and Wiley, and is
overseeing the development of the first phase in the
threaded publications concept, Linked Reports of Clinical
Trials.
Linked Reports of Clinical Trials
The Linked Reports of Clinical Trials project will adapt
the existing CrossMark standard to capture additional
metadata about an article, namely the clinical trial
number, the trial registry and the relation to the
primary trial report, and associate that information
with the article DOI on publication. A query to this
CrossRef database will then return all articles related to
that clinical trial number. As all the metadata will be
open access (CC0 license) [13], with no copyright, it
will be possible to access this article ‘thread’ either
through the CrossMark interface or independently
through an application programming interface (API).
A pilot evaluation of this system is set to begin towards
the end of 2014, trialling how to adapt existing article
workflows to capture these additional metadata prospect-
ively and in an efficient and sustainable manner. For the
initial pilot phase, only those articles for which the clinical
trial number is currently required for publication by the
publishers involved will be included; this includes study
protocols [14] and updates [15], statistical analysis plans
[16], primary results papers [17] and secondary analyses
[18]. Following successful implementation on this subset,
the scope will be expanded to capture the clinical trial
number for additional article types related to clinical trials,
such as case reports of adverse events, commentaries and
editorials.
Conclusion
The medical literature is vast and it is impossible to keep
up with the deluge of new research articles. With ongoing
concerns regarding manipulation of the outcomes and
analyses reported in medical research, it is increasingly
important that researchers are able to easily identify and
access all publications relating to a specific clinical trial, in
order to obtain the complete picture and to evaluate bias
or selective reporting reliably. Recent developments andinnovations within the threaded publications initiative and
the Linked Reports of Clinical Trials project demonstrate
progress towards the ideal of making all trial information
readily available.
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